Speaker Name: Prof. John McMurray, Professor of Medical Cardiology, Cardiovascular & Metabolic Health, University of Glasgow.

Watch this session to:

• Review EMPEROR-Preserved and DELIVER data for SGLT2i in reducing CV death or HHF.
• Understand key mechanisms of SGLT2i, including natriuresis and improved myocardial energetics.
• Recognize cardiac remodeling benefits, including reduced LA volume and LV mass.
• Discuss the role of finerenone in reducing worsening HF events with potassium monitoring.
• Evaluate adjunct approaches in HFpEF, including GLP-1 RA and selective beta-blocker withdrawal.